SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-23-003486
Filing Date
2023-02-03
Accepted
2023-02-03 10:44:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13ga.htm SC 13G/A 74048
  Complete submission text file 0001493152-23-003486.txt   75668
Mailing Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121
Business Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121 (858) 436-1000
Gene Biotherapeutics, Inc. (Subject) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-51647 | Film No.: 23584230
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 6888 SOUTH IRVINGTON COURT AURORA CO 80016
Business Address
Jemapete Christopher J (Filed by) CIK: 0001741021 (see all company filings)

Type: SC 13G/A